NBIXbenzinga

Needham Upgrades Neurocrine Biosciences to Buy, Announces $138 Price Target

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 15, 2025 by benzinga